FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
FINAL PROGR AM - American Society of Gene & Cell Therapy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>AM</strong>ERICAN SOCIETY OF GENE THERAPY • Final Program 151<br />
EXHIBITOR DESCRIPTIONS<br />
Kemp Biotechnologies, Inc.<br />
7307 Governors Way<br />
Frederick, MD 21704<br />
Phone: 301-620-7100<br />
Fax: 301-620-0162<br />
E-Mail: b.miller@kempbiotech.com<br />
www.kempbiotech.com<br />
Booth Number: 407<br />
Kemp Biotechnologies, Inc. will present a proprietary<br />
nontoxic transfection reagent and a proprietary transfection<br />
process, which enables AAV viral vector production<br />
via cotransfection <strong>of</strong> suspension 293 cells. This service is<br />
a scalable, cost-effective alternative to the time-consuming<br />
process <strong>of</strong> transfecting large quantities <strong>of</strong> plates <strong>of</strong><br />
adherent 293 cell cultures to generate AAV vector stocks.<br />
Lark Technologies<br />
9441 W. Sam Houston Parkway South, Suite 103<br />
Houston, TX 77099<br />
Phone: 713-779-3663<br />
Fax: 713-779-1661<br />
E-Mail: sales@lark.com<br />
www.lark.com<br />
Booth Number: 305<br />
Lark, A Genaissance Company is a leading contract<br />
research organization providing research grade and<br />
regulatory submission services including DNA sequencing,<br />
quantitative PCR analysis, and genetic stability<br />
testing. All <strong>of</strong> Lark’s regulatory submission services<br />
comply with Good Laboratory Practices as specified by<br />
the FDA.<br />
Mary Ann Liebert, Inc.<br />
2 Madison Ave.<br />
Larchmont, NY 10538<br />
Phone: 914-834-3100<br />
Fax: 914-834-3771<br />
E-Mail: info@liebertpub.com<br />
www.liebertpub.com<br />
Booth Number: 112<br />
Mary Ann Liebert, Inc. Publishers invites you to come by<br />
our booth #112, and take a complementary copy <strong>of</strong><br />
Human <strong>Gene</strong> <strong>Therapy</strong>, <strong>Gene</strong>tic Testing, <strong>Gene</strong>tic Engineering<br />
News and other related publications.<br />
MDS Pharma Services<br />
2350 Cohen Street<br />
Saint-Laurent (Montreal)<br />
Quebec, H4R 2N6<br />
Canada<br />
Phone: 514-333-0033<br />
Fax: 514-333-8861<br />
E-Mail: info@mdsps.com<br />
www.mdsps.com<br />
Booth Number: 309<br />
MDS Pharma Services’ biopharmaceuticals group<br />
executes rapid and rigorous GLP/cGMP safety and<br />
analytical testing. Our state-<strong>of</strong>-the-art facility in Bothell,<br />
Washington, features restricted-access laboratories and<br />
FDA and ICH compliance. Suites consist <strong>of</strong> BSL-2/BSL-<br />
3 virology labs, cell culture and cell-banking (cGMP)<br />
facilities, protein chemistry and PCR rooms. For more<br />
information, visit www.mdsps.com.<br />
Mirus Bio Corporation<br />
505 S. Rosa Road, Suite 104<br />
Madison, WI 53705<br />
Phone: 608-441-2824<br />
Fax: 608-441-2849<br />
E-Mail: Claire.ruzicka@mirusbio.org<br />
www.mirusbio.com<br />
Booth Number: 505<br />
Mirus Bio provides state-<strong>of</strong>-the-art nucleic acid delivery<br />
and labeling reagents for in vitro and in vivo research.<br />
TransIT â reagents achieve high efficiency/low toxicity<br />
transfections in a variety <strong>of</strong> cell lines and applications<br />
including siRNA delivery. Label IT â non-enzymatic<br />
nucleic acid labeling kits are optimized for hybridization<br />
and tracking applications.<br />
Molecular Medicine Bioservices, Inc.<br />
6219 el Camino Real<br />
Carlsbad, CA 92009<br />
Phone: 760-918-0007<br />
Fax: 760-918-0076<br />
E-Mail: dbacker@molecularmed.com<br />
www.molecularmed.com<br />
Booth Number: 315<br />
Molecular Medicine BioServices, Inc. provides enabling<br />
technologies for viral-based therapeutics. Located in<br />
Carlsbad, CA, the company is a leading contract manufacturing<br />
and clinical production resource for companies<br />
engaged in vaccine and gene therapy development.<br />
Molecular Medicine is committed to supporting clients<br />
from development through production and into clinical<br />
approval.